Vir Biotechnology Inc Cash Flow Reinvestment Rate
Vir Biotechnology Inc cash flow reinvestment rate. Vir Biotechnology Inc (VIR) has a Cash Flow Reinvestment Rate of 1.60x as of June 2026, reinvesting $197.14 Million (capex $32.00K plus investments $-197.11 Million) from operating cash flow of $123.33 Million. Explore Vir Biotechnology Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Vir Biotechnology Inc (2022–2022)
Cash flow reinvestment rate of Vir Biotechnology Inc from 2022 to 2022. Historical reinvestment intensity for Vir Biotechnology Inc across 1 annual periods. Explore VIR capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Vir Biotechnology Inc Cash Flow Reinvestment Rate by Year (2022–2022)
Vir Biotechnology Inc cash flow reinvestment rate by year from 2022 to 2022. Year-by-year capital reinvestment analysis for Vir Biotechnology Inc. For the full cash flow conversion analysis, see VIR cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.76x | $1.26 Billion | $1.66 Billion | $68.01 Million | — |